Cepheid

Cepheid is a molecular diagnostics company that provides molecular systems and tests for organisms and genetic-based diseases. Headquartered in Sunnyvale, California, Cepheid is dedicated to the development, manufacturing, and marketing of accurate and easy-to-use molecular diagnostic and testing systems. By automating highly complex and time-consuming manual processes, the company has developed a genetic testing system capable of conducting complex analyses on organisms. The Resistance Plus MG test is one of Cepheid's flexible cartridge programs launched in early 2019. Through the automation of these intricate and labor-intensive procedures, the company’s solutions offer institutions of all sizes a more efficient way to perform complex genetic testing for biological and genetic diseases. Leveraging its robust molecular biology capabilities, the company focuses on applications where accurate, rapid, and actionable test results are most needed, such as controlling infectious diseases and cancer.